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Abstract
Purposes The aim of this retrospective study was to
investigate the effect of chronic kidney disease (CKD) on
outcomes after coronary artery bypass grafting (CABG),
and to determine whether preoperative estimated glomer-
ular filtration rate (eGFR) can be a predictor of long-term
outcomes after CABG.
Methods 486 Japanese patients who underwent isolated
CABG between December 2000 and August 2010 were
evaluated. Preoperative eGFR was estimated by the Japa-
nese equation according to guidelines from the Japanese
Society of Nephrology. We defined CKD as a preoperative
eGFR of less than 60 ml/min/1.73 m2. 203 patients had
CKD (CK group) and 283 patients did not (N group).
Results During a mean observation time of 53 months, the
overall survival rate was significantly lower in the CK group
than in the N group (p = 0.0044). Similarly, the CK group
had significantly more unfavorable results with regard to
freedom from cardiac death, major adverse cardiovascular
and cerebrovascular events (MACCE), and hemodialysis.
Using multivariate analyses, preoperative eGFR was an
independent predictor of all-cause mortality (HR 0.983;
p = 0.026), cardiac mortality (HR 0.963; p = 0.006), and
incidence of MACCE (HR 0.983; p = 0.002).
Conclusions The CK group had significantly more unfa-
vorable outcomes than the N group. Preoperative eGFR
was an independent predictor of long-term outcomes after
CABG in Japanese patients.
Keywords Estimated glomerular filtration rate 
Long-term outcomes  Coronary artery bypass
grafting  Chronic kidney disease
Introduction
Severe renal dysfunction, in particular, which requires
dialysis, has been identified as a risk factor for adverse
outcomes after coronary artery bypass grafting (CABG) [1–
3]. Chronic kidney disease (CKD) that does not require
dialysis, which has been defined according to levels of
serum creatinine or estimated glomerular filtration rate
(eGFR) calculated by the Cockcroft–Gault equation, has
also been identified as a predictor of poor outcomes after
CABG [4–11]. It has been reported recently that eGFR
calculated using the Modification of Diet in Renal Disease
(MDRD) study equation is a more accurate marker of renal
function than either creatinine clearance or eGFR calculated
by the Cockroft–Gault equation. Thus, the calculation of
eGFR in this way could aid in the diagnosis of mild renal
impairment, even in patients with normal or nearly normal
creatinine levels [12]. A limited number of studies have
defined CKD according to eGFR calculated using the
MDRD study equation, assessed the impact of CKD on
long-term outcomes after CABG, and determined whether
preoperative eGFR is a predictor of long-term outcomes
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after CABG [13–15]. It has been also reported that the
revised Japanese equation is more accurate for the Japanese
population than the MDRD study equation using the pre-
vious Japanese Society of Nephrology Chronic Kidney
Disease Initiative [16]. In this study, we calculated eGFR
and defined CKD using the Japanese equation according to
guidelines from the Japanese Society of Nephrology. The
aim of this retrospective study was to investigate the effect
of CKD on early and long-term outcomes after CABG in
Japanese patients, and to determine whether preoperative
eGFR is a predictor of long-term outcomes after CABG.
Patients and methods
Between December 2000 and April 2010, 527 consecutive
Japanese patients underwent isolated CABG at our institu-
tion. Excluding 41 patients who underwent preoperative
hemodialysis (HD) or previous cardiac surgery, 486 patients
were evaluated.
Definition of CKD
We defined CKD as a preoperative eGFR of less than 60 ml/
min/1.73 m2 according to guidelines from the National
Kidney Foundation [17–19]. eGFR was calculated using the
Japanese equitation according to guidelines from the Japa-
nese Society of Nephrology [16]: eGFR (ml/min/
1.73 m2) = 194 9 (serum creatinine [mg/dl])-1.094 9 (age
[years])-0.287 9 0.739 (in the case of female patients). Note
that all our patients were Japanese. Preoperative eGFR was
calculated at admission.
Definition of end points
The end points studied overall death, cardiac death, inci-
dence of major adverse cardiovascular and cerebrovascular
events (MACCE) and introduction to HD. Cardiac death
included deaths caused by myocardial infarction, heart
failure, or sudden death. Follow-up information was
obtained from each patient’s hospital records, interviews at
the time of outpatient visit, telephone calls and from
referring physicians.
Surgical technique
Since October 2001, we have performed off-pump CABG
(OPCAB) for patients requiring coronary artery revascular-
ization as the first-line treatment. The internal thoracic artery
(ITA), gastroepiploic artery (GEA), and radial artery (RA)
were harvested in all cases with the skeletonization tech-
nique. The basic strategy for myocardial revascularization
was in situ grafting of bilateral ITAs to the left coronary
system, with complementary RA or saphenous vein graft
(SVG). In most patients, the in situ left ITA was grafted to the
left anterior descending (LAD) artery, and the in situ right
ITA was grafted to the circumflex branches. RA and SVG
were used for aorto-coronary bypass to revascularize the
posteroinferior wall. However, in cases of critical coronary
stenosis, GEA was used as an in situ graft. If it was necessary
to revascularize several vessels in the left coronary system,
and to avoid manipulation of the ascending aorta with highly
arteriosclerosis, the in situ left ITA was anastomosed to the
LAD artery, the RA graft was anastomosed to the in situ right
ITA in an end-to-side fashion, and this was grafted to the
circumflex branches and right coronary artery.
Statistical analysis
Normally distributed continuous data were presented as
mean (SD). Discrete variables were compared with the v2
test, and continuous variables were compared with the
Mann–Whitney test. The Kaplan–Meier method was used
for determining the overall survival, freedom from cardiac
death, freedom from MACCE, and freedom from HD,
while the log-rank test was applied for statistical compar-
ison. Potential independent predictors of outcomes were
identified by univariate Cox regression analysis. All uni-
variable predictors were then entered in a stepwise manner
into a multivariable Cox regression analysis, with entry and
retention set at a significance level of p \ 0.05. Hazard
ratios (HRs) were reported with 95 % confidence intervals
(CIs). All statistical analyses were carried out using Dr.
SPSS II (SPSS, Inc., Chicago, IL, USA) for Windows.
Results
Preoperative data
Patients’ preoperative characteristics are shown in Table 1: 203
(42 %) patients had CKD (CK group) and 283 (58 %) patients
did not (N group). Mean serum creatinine and eGFR were
1.24 ± 0.50 mg/dl and 45.9 ± 10.3 ml/min/1.73 m2, respec-
tively, in the CK group, and 0.76 ± 0.13 mg/dl and
77.1 ± 13.8 ml/min/1.73 m2, respectively, in the N group.
There were no significant differences in characteristics between
the 2 groups except for age, proteinuria, preoperative hemo-
globin, history of stroke, and old myocardial infarction (OMI).
Age was higher in the CK group (71.7 ± 8.5 years) than in the
N group (65.7 ± 10.2 years, p\0.01), and preoperative
hemoglobin was lower in the CK group (12.3 ± 1.8 g/dl) than
in the N group (13.3 ± 1.5 g/dl, p\ 0.01). Proteinuria, stroke,
and OMI were more frequent in the CK group than in the N
group (proteinuria: 22 vs. 10 %, p \0.01; stroke: 21 vs. 13 %,
p = 0.02; OMI: 48 vs. 37 %, p = 0.02).
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Intraoperative data
Intraoperative data are shown in Table 2. There were no
significant differences between the 2 groups except for RA
use and transfusion. RA grafts were used less often in the
CK group (37 vs. 48 %, p = 0.02), and transfusion was
used more frequently in the CK group than in the N group
(65 vs. 44 %, p \ 0.01).
Postoperative outcomes
Postoperative outcomes are shown in Table 3. Hospital
death occurred in the case of 3 patients in the CK group.
Two of these deaths were caused by low output syndrome,
and one was caused by pneumonia. There was no special
treatment for CKD in the intraoperative and postoperative
management, and there were no significant differences
between the 2 groups with regard to the number of hospital
deaths, postoperative course, and complications.
Long-term outcomes
Long-term outcomes are shown in Table 4. During the
mean follow-up period of 53 ± 33 months, cardiac deaths
occurred in the case of 18 patients in the CK group and 8
patients in the N group. Three of these deaths in the CK
group were caused by acute myocardial infarction (AMI),
and 15 were caused by heart failure. No patients were
introduced to HD in the N group, whereas 10 patients were
introduced to HD in the CK group. Kaplan–Meier curves








myocardial infarction, OMI old
myocardial infarction, EF
ejection fraction, LMT left main
trunk
CK (n = 203) N (n = 283) p value
Age (year) 71.7 ± 8.5 65.7 ± 10.2 \0.01
Male 152 (74 %) 234 (83 %) 0.04
Creatinine (mg/dl) 1.24 ± 0.50 0.76 ± 0.13 \0.01
eGFR (ml/min/1.73 m2) 45.9 ± 10.3 77.1 ± 13.8 \0.01
Proteinuria 45 (22 %) 29 (10 %) \0.01
Hypertension 144 (71 %) 186 (66 %) NS
Dyslipidemia 80 (40 %) 126 (45 %) NS
Diabetes 105 (52 %) 133 (47 %) NS
Stroke 42 (21 %) 36 (13 %) 0.02
PAD 23 (11 %) 20 (7 %) NS
Smoking history 122 (60 %) 189 (67 %) NS
Hemoglobin (g/dl) 12.3 ± 1.8 13.3 ± 1.5 \0.01
Cardiac data
Prior PCI 21 (10 %) 35 (12 %) NS
AMI \3 weeks ago 122 (60 %) 189 (67 %) NS
OMI 97 (48 %) 104 (37 %) 0.02
Emergency 39 (12 %) 46 (16 %) NS
NYHA III–IV 38 (19 %) 42 (15 %) NS
Low EF (\30 %) 22 (11 %) 20 (7 %) NS
Coronary artery disease
LMT disease 46 (23 %) 62 (22 %) NS
3 vessels 122 (60 %) 182 (64 %) NS
2 vessels 69 (34 %) 88 (31 %) NS
1 vessels 12 (6 %) 13 (5 %) NS
Table 2 Intraoperative data
CK (n = 203) N (n = 283) p value
OPCAB 185 (91 %) 233 (82 %) NS
Operation time (min) 311 ± 73 320 ± 76 NS
No. distal anastomosis 3.2 ± 1.2 3.2 ± 1.2 NS
Grafts
Single ITA 53 (26 %) 87 (30 %) NS
Bilateral ITAs 149 (73 %) 196 (70 %) NS
All arterial grafts use 157 (77 %) 232 (82 %) NS
RA use 75 (37 %) 136 (48 %) 0.02
GEA use 51 (25 %) 76 (27 %) NS
SVG use 46 (23 %) 51 (18 %) NS
Composite grafting 37 (18 %) 37 (13 %) NS
Transfusion 131 (65 %) 124 (44 %) \0.01
OPCAB off-pump coronary artery grafting, ITA internal thoracic
artery, RA radial artery, GEA gastroepiploic artery, SVG saphenous
vein graft
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group had significantly poorer overall survival (at 5 and
9 years, 81 and 60 % vs. 91 and 77 %, respectively,
p = 0.0044), freedom from cardiac death (at 5 and 9 year,
91 and 80 % vs. 97 and 95 %, respectively, p = 0.0013),
freedom from MACCE (at 5 and 9 year, 71 and 48 % vs.
83 and 78 %, respectively, p \ 0.0001), and freedom from
HD (at 5 and 9 years, 93 and 92 % vs. 100 and 100 %,
respectively, p = 0.0001).
Predictors of long-term outcomes were identified by uni-
variate and multivariate Cox regression analyses. Predictors
of all-cause mortality identified by univariate and multivariate
Cox regression analyses are shown in Table 5. Univariate
analysis identified age, serum creatinine, preoperative eGFR
(considered as a continuous variable), proteinuria, dyslipide-
mia, stroke, peripheral artery disease (PAD), smoking history,
preoperative hemoglobin (considered as a continuous vari-
able), NYHA III–IV, low ejection fraction (EF\30 %), OMI,
AMI, emergency, transfusion, RA use, GEA use, and SVG use
as predictors of long-term mortality. Serum creatinine and
eGFR were mathematically related. However, in this cohort,
when eGFR was used as a predictor, creatinine provided no
additional prognostic information. Therefore, eGFR was used
in subsequent forward conditional multivariable models. All
predictors identified by univariate analysis, except serum
creatinine, were used in the multivariate analysis. Preopera-
tive eGFR (HR 0.983; 95 % CI 0.969–0.998; p = 0.026) and
transfusion (HR 2.227; 95 % CI 1.143–4.338; p = 0.019)
proved to be independent predictors of all-cause mortality.
Exclusion of age (which is a component of eGFR) did not
change in the result of this model. Predictors of cardiac mor-
tality, incidence of MACCE, and introduction to HD identi-
fied by multivariate Cox regression analysis are shown in
Table 6. Preoperative eGFR proved to be an independent
predictor of cardiac mortality (HR 0.963; 95 % CI
0.938–0.990; p = 0.006) and incidence of MACCE (HR
0.983; 95 % CI 0.972–0.994; p = 0.002). Again, exclusion of
age did not alter this result. Preoperative hemoglobin and
emergency were independent predictors of cardiac mortality,
where PAD was an independent predictor of the incidence of
MACCE.
In 10 patients introduced to HD, characteristics are shown
in Table 7. The mean serum creatinine and preoperative
eGFR were 2.32 ± 1.02 mg/dl (range 1.45–4.36 mg/dl) and
25.2 ± 9.51 ml/min/1.73 m2 (range 11.8–39.5 ml/min/
1.73 m2). The mean periods from CABG to HD were
29.3 ± 22.2 months (range 1–63 months). Three patients
were in CKD stage 3 (30–60 ml/min/1.73 m2) and two of
them exacerbated diabetic nephropathy. Predictors of intro-
duction to HD in patients with CKD identified by univariate
and multivariate Cox regression analyses are shown in
Table 3 Postoperative
outcomes
ICU intensive care unit, HD
hemodialysis, SSI surgical site
infection
CK (n = 203) N (n = 283) p value
Hospital death 3 (1.5 %) 0 (0 %) NS
Postoperative course
Intubation [24 h 14 (6.9 %) 17 (6.0 %) NS
ICU stay (day) 3.4 ± 7.1 2.6 ± 3.6 NS
Hospital stay (day) 15 ± 14 14 ± 11 NS
Complications
Re-exploration 1 (0.5 %) 1 (0.4 %) NS
Perioperative MI 3 (1.5 %) 2 (0.7 %) NS
Stroke 1 (0.5 %) 1 (0.5 %) NS
Respiratory failure 12 (5.9 %) 8 (2.8 %) NS
Perioperative HD 2 (1.0 %) 0 (0 %) NS
Late tamponade 1 (0.5 %) 2 (0.7 %) NS
Atrial fibrillation 52 (26 %) 60 (21 %) NS
Ventricular arrhythmia 4 (2.0 %) 2 (0.7 %) NS
Mediastinitis 2 (1.0 %) 2 (0.7 %) NS
SSI 4 (2.0 %) 5 (1.8 %) NS
Table 4 Long-term outcomes (mean 53 months)
CK (n = 203) N (n = 283)
MACCE
AMI 5 (2.5 %) 8 (2.8 %)
Heart failure 24 (12 %) 6 (2.1 %)
PCI 17 (8.4 %) 16 (5.7 %)
Cerebrovascular events 11 (5.4 %) 15 (7.4 %)
Late death
Cardiac death 18 (8.9 %) 8 (2.8 %)
Cerebrovascular death 7 (3.4 %) 4 (1.4 %)
Non cardiac death 15 (7.4 %) 21 (7.4 %)
HD 10 (4.9 %) 0 (0 %)
MACCE major adverse cardiovascular and cerebrovascular events
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Table 8. Preoperative eGFR of less than 30 ml/min/1.73 m2
(HR 71.04; 95 % CI 7.037–717.2; p \ 0.001), proteinuria
(HR 7.565; 95 % CI 1.221–46.86; p = 0.030), diabetes (HR
7.844; 95 % CI 1.026–59.97; p = 0.047), and preoperative
hemoglobin (HR 0.371; 95 % CI 0.190–0.727; p = 0.004)
were identified as independent predictors of introduction to
HD by multivariate analysis. When preoperative eGFR is
considered as a continuous variable, similar significant results
were obtained (HR 0.828; 95 % CI 0.743–0.924; p \ 0.001).
Discussion
Glomerular filtration rate is accepted as the best overall
measure of renal function. GFR is measured as the urinary
or plasma clearance of a filtration marker such as inulin.
However, measuring the clearance of inulin is complex and
expensive. In routine clinical practice, eGFR calculated
from the MDRD study equation is the most accurate
marker of renal function [12] and revised Japanese equa-
tion is more accurate for the Japanese population than the
MDRD study equation [16].
Several studies have reported poor outcomes in patients
with renal dysfunction after CABG, but long-term data are
scarce. In addition, most studies, that have shown an
association between preoperative renal dysfunction and a
higher incidence of morbidity and mortality after CABG,
have concentrated on patients with elevated serum creati-
nine or decreased eGFR calculated by the Cockcroft–Gault
equation [1–11]. In order to evaluate renal function accu-
rately in Japanese patients, this study defined CKD as a
preoperative eGFR of less than 60 ml/min/1.73 m2, which
was calculated from the Japanese equation. The results
confirm the major impact of CKD on the long-term out-
comes after CABG.
The association between CKD and poor outcomes after
CABG in patients who are not on dialysis has multiple
possible explanations. Firstly, increased risk may be
attributed to a multitude of concomitant factors seen in
patients with CKD, including advanced age, low preoper-
ative hemoglobin, history of OMI, and stroke (Table 1).
CKD is associated with the processes of these diseases,
which are themselves determinants of poor outcomes [20].
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Fig. 1 Kaplan–Meier curves show that the CK group has significantly more unfavorable long-term outcomes than N group
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with renal function, and low ejection fraction are known to
be associated with an increased risk of morbidity and
mortality following CABG [21–23]. History of stroke is
also known to be a predictor of cerebrovascular events after
cardiac surgery requiring cardiopulmonary bypass [24].
Using univariate analysis, the current study confirmed that
these preoperative factors are predictors of long-term out-
comes after CABG (Table 5). Secondly, CKD is a pow-
erful independent risk factor for cardiovascular disease.
This may reflect the increased inflammation and oxidative
stress associated with reduced renal function. In addition,
kidney dysfunction may be associated with many other
physical changes including high levels of homocysteine,
hyperuricemia, hypercalcemia, and uremia, all of which
have detrimental cardiovascular effects [25, 26]. Thirdly, it
has been reported that patients with CKD have a greater
frequency of triple vessel disease and left main involve-
ment, when compared to patients without CKD [13]. This
indicates that patients with CKD may have more extensive
coronary disease preoperatively than patients without
CKD. The deleterious consequences of CKD may lead to a
global reduction in oxygen supply to the myocardium, due
to severe damage to epicardial coronary macrovessels and
depressed coronary reserve secondary to microvessel dis-
ease [27]. In our study, there were no significant differ-
ences between the 2 groups in the frequency of triple vessel
disease and left main trunk disease, or the number of distal
anastomoses. However, it is possible that these patients still
have coronary microvessel disease.
The surgical strategy used for CABG, including graft
selection, may be an important predictor of outcomes for
patients with CKD. Recent reviews have demonstrated that
in patients with CKD, OPCAB is less deleterious than
Table 5 Predictors of long-




Univariate analysis Multivariate analysis
HR (95 % CI) p value HR (95 % CI) p value
Age 1.069 (1.039–1.100) \0.001 1.026 (0.993–1.060) 0.118
Male 1.109 (0.619–1.989) 0.729
Creatinine 2.009 (1.516–2.906) \0.001
eGFR 0.972 (0.960–0.985) \0.001 0.983 (0.969–0.998) 0.026
Proteinuria 1.846 (1.058–3.219) 0.031 1.116 (0.601–2.071) 0.728
Hypertension 1.050 (0.643–1.715) 0.844
Dyslipidemia 0.527 (0.309–0.899) 0.019 0.730 (0.417–1.278) 0.271
Diabetes 1.367 (0.860–2.172) 0.186
Stroke 2.309 (1.349–3.954) 0.002 1.704 (0.893–3.251) 0.106
PAD 2.996 (1.641–5.472) \0.001 1.278 (0.632–2.585) 0.495
Smoking history 1.029 (0.640–1.653) 0.907
Hemoglobin 0.773 (0.670–0.892) \0.001 0.970 (0.819–1.149) 0.724
NYHA III–IV 3.611 (2.203–5.918) \0.001 1.473 (0.636–3.411) 0.366
Low EF (\30 %) 4.131 (2.360–7.232) \0.001 1.978 (1.001–3.910) 0.05
OMI 1.751 (1.100–2.788) 0.018 1.392 (0.834–2.324) 0.206
Prior PCI 1.208 (0.619–2.358) 0.588
AMI \3 weeks ago 4.010 (2.231–7.208) \0.001 1.290 (0.524–3.176) 0.58
Emergency 3.421 (2.111–5.546) \0.001 1.402 (0.632–3.113) 0.406
Pump 0.806 (0.422–1.539) 0.514
Operation time 0.997 (0.994–1.001) 0.117
Transfusion 4.362 (2.500–7.609) \0.001 2.227 (1.143–4.338) 0.019
RA use 0.589 (0.355–0.975) 0.039 1.020 (0.545–1.908) 0.952
GEA use 0.541 (0.314–0.931) 0.027 0.735 (0.393–1.372) 0.333
SVG use 2.031 (1.257–3.281) 0.004 1.289 (0.663–2.503) 0.454
Bilateral ITAs 1.221 (0.738–2.020) 0.436
Table 6 Multivariate analysis
HR (95 % CI) p value
Cardiac mortality
eGFR 0.963 (0.938–0.990) 0.006
Hemoglobin 0.711 (0.534–0.946) 0.019
Emergency 2.978 (1.030–8.609) 0.044
Incidence of MACCE
eGFR 0.983 (0.972–0.994) 0.002
PAD 2.331 (1.293–4.203) \0.01
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conventional CABG, and the use of total arterial grafts,
especially bilateral ITAs have better outcomes after CABG
[4, 28, 29]. We generally use the bilateral ITAs in these
patients; with this approach, the RA is preserved as an
arteriovenous fistula for vascular access in the future
(Table 2). As a result, all arterial grafts are used less fre-
quently than SVG in patients with CKD, when compared to
patients without CKD. In this study, there were no differ-
ences between the 2 groups in early outcomes (Table 3);
however, SVG use was identified as a predictor of poorer
long-term outcomes by univariate analysis (Table 5).
Therefore, we have confirmed the importance of using
in situ bilateral ITAs, considering the advantage of long-
term graft patency. In addition, it may be necessary to more
clearly define preoperative eGFR criteria for RA use and
evaluating the risk of HD. Considering this result
(Table 8), we propose that RA should not be used in CKD
patients with a preoperative eGFR of less than 30 ml/min/
1.73 m2, proteinuria, diabetes, or low hemoglobin to pre-
vent introduction to HD in the future.
The significantly increased risk of all-cause death, car-
diac death, and the incidence of MACCE in patients with
CKD indicates that postoperative treatment for cardiorenal
protection is necessary after CABG. It has been reported
that CKD is associated with decreased utilization of key
cardiovascular medications such as aspirin, b-blockers,
statins, angiotensin-converting enzyme inhibitors, and
angiotensin receptor blockers [30]. Since reduction in renal
function is a powerful predictor of adverse outcomes,
preservation of renal function is directly linked with sec-
ondary prevention of cardiovascular events after CABG
and in other cardiovascular disease settings.
Limitations
This study has several limitations. Firstly, our study pop-
ulation was small, and the follow-up period was short.
Secondly, preoperative eGFR was based on a single mea-
surement at admission. However, eGFR may fluctuate,
particularly in patients with unstable hemodynamics and
varying medical therapy. Thirdly, no data were available
on medications taken after discharge, because the patients
received postoperative treatment from different hospitals.
However, most patients were discharged with aspirin, b-
blocker, statin, and angiotensin-converting enzyme inhibi-
tor or angiotensin receptor blocker therapy.
Conclusions
Our study clearly demonstrates that CKD has an unfavor-
able impact on long-term outcomes after CABG and pre-
operative eGFR is a significant predictor of long-term
outcomes after CABG. These results lead us to recommend
Table 7 Characteristics
Age (year) 69.0 ± 10.4
Male 8
Creatinine (mg/dl) 2.32 ± 1.02
eGFR (ml/min/1.73 m2) 25.2 ± 9.5
CKD Stage 5 2
CKD Stage 4 5
CKD Stage 3 3








Hemoglobin (g/dl) 12.3 ± 1.8
NYHA III–IV 3
Low EF (\30 %) 2
3 vessels disease 5
2 vessels disease 5
OPCAB 10





Table 8 Predictors of the
introduction to HD by
univariate and multivariate Cox
regression analysis in patients
with CKD
Univariate analysis Multivariate analysis
HR (95 % CI) p value HR (95 % CI) p value
eGFR \30 30.10 (7.723–117.3) \0.001 71.04 (7.037–717.2) \0.001
Proteinuria 21.91 (4.625–103.8) \0.001 7.565 (1.221–46.86) 0.03
Diabetes 4.969 (1.048–23.56) 0.043 7.844 (1.026–59.97) 0.047
Stroke 5.212 (1.485–18.30) 0.01 3.019 (0.651–14.01) 0.158
PAD 4.127 (1.065–16.00) 0.04 0.553 (0.091–3.350) 0.519
Hemoglobin 0.497 (0.331–0.749) \0.001 0.371 (0.190–0.727) 0.004
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the incorporation of preoperative eGFR into the risk
assessments of long-term outcomes after CABG.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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